Repevax vaccine suspension for injection 0.5ml pre-filled syringes
Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Diphtheria toxoid; Tetanus toxoid; Pertussis antigens; Human poliovirus type 1 inactivated; Human poliovirus type 2 inactivated; Human poliovirus type 3 inactivated
Available from:
sanofi pasteur MSD Ltd
ATC code:
J07CA02
INN (International Name):
Diphtheria toxoid; Tetanus toxoid; Pertussis antigens; Human poliovirus type 1 inactivated; Human poliovirus type 2 inactivated; Human poliovirus type 3 inactivated
Pharmaceutical form:
Suspension for injection
Administration route:
Subcutaneous; Intramuscular
Class:
No Controlled Drug Status
Prescription type:
Valid as a prescribable product
Product summary:
BNF: 14040000
